The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

C. Verslype; E. Van Cutsem; M. Dicato; N. Arber; J. D. Berlin; D. Cunningham; A. De Gramont; E. Diaz-Rubio; M. Ducreux; T. Gruenberger; D. Haller; K. Haustermans; P. Hoff; D. Kerr; R. Labianca; M. Moore; B. Nordlinger; A. Ohtsu; P. Rougier; W. Scheithauer; H. J. Schmoll; A. Sobrero; J. Tabernero; C. van de Velde

doi:10.1093/annonc/mdp281

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

C. Verslype, E. Van Cutsem^*, M. Dicato, N. Arber, J. D. Berlin, D. Cunningham, A. De Gramont, E. Diaz-Rubio, M. Ducreux, T. Gruenberger, D. Haller, K. Haustermans, P. Hoff, D. Kerr, R. Labianca, M. Moore, B. Nordlinger, A. Ohtsu, P. Rougier, W. ScheithauerH. J. Schmoll, A. Sobrero, J. Tabernero, C. van de Velde

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

Abstract

This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	Annals of Oncology
Volume	20
Issue number	SUPPL.7
DOIs	https://doi.org/10.1093/annonc/mdp281
State	Published - 2009
Externally published	Yes

Keywords

Chemoembolisation
Hepatocellular carcinoma
Liver transplantation
Sorafenib

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdp281

Cite this

Verslype, C., Van Cutsem, E., Dicato, M., Arber, N., Berlin, J. D., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Gruenberger, T., Haller, D., Haustermans, K., Hoff, P., Kerr, D., Labianca, R., Moore, M., Nordlinger, B., Ohtsu, A., Rougier, P., ... van de Velde, C. (2009). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Annals of Oncology, 20(SUPPL.7), 1-6. https://doi.org/10.1093/annonc/mdp281

@article{ff4bb4cd68cb481db489876ecce451e2,

title = "The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008",

abstract = "This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.",

keywords = "Chemoembolisation, Hepatocellular carcinoma, Liver transplantation, Sorafenib",

author = "C. Verslype and {Van Cutsem}, E. and M. Dicato and N. Arber and Berlin, {J. D.} and D. Cunningham and {De Gramont}, A. and E. Diaz-Rubio and M. Ducreux and T. Gruenberger and D. Haller and K. Haustermans and P. Hoff and D. Kerr and R. Labianca and M. Moore and B. Nordlinger and A. Ohtsu and P. Rougier and W. Scheithauer and Schmoll, {H. J.} and A. Sobrero and J. Tabernero and {van de Velde}, C.",

year = "2009",

doi = "10.1093/annonc/mdp281",

language = "אנגלית",

volume = "20",

pages = "1--6",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "SUPPL.7",

}

Verslype, C, Van Cutsem, E, Dicato, M, Arber, N, Berlin, JD, Cunningham, D, De Gramont, A, Diaz-Rubio, E, Ducreux, M, Gruenberger, T, Haller, D, Haustermans, K, Hoff, P, Kerr, D, Labianca, R, Moore, M, Nordlinger, B, Ohtsu, A, Rougier, P, Scheithauer, W, Schmoll, HJ, Sobrero, A, Tabernero, J & van de Velde, C 2009, 'The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008', Annals of Oncology, vol. 20, no. SUPPL.7, pp. 1-6. https://doi.org/10.1093/annonc/mdp281

TY - JOUR

T1 - The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

AU - Verslype, C.

AU - Van Cutsem, E.

AU - Dicato, M.

AU - Arber, N.

AU - Berlin, J. D.

AU - Cunningham, D.

AU - De Gramont, A.

AU - Diaz-Rubio, E.

AU - Ducreux, M.

AU - Gruenberger, T.

AU - Haller, D.

AU - Haustermans, K.

AU - Hoff, P.

AU - Kerr, D.

AU - Labianca, R.

AU - Moore, M.

AU - Nordlinger, B.

AU - Ohtsu, A.

AU - Rougier, P.

AU - Scheithauer, W.

AU - Schmoll, H. J.

AU - Sobrero, A.

AU - Tabernero, J.

AU - van de Velde, C.

PY - 2009

Y1 - 2009

N2 - This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.

AB - This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.

KW - Chemoembolisation

KW - Hepatocellular carcinoma

KW - Liver transplantation

KW - Sorafenib

UR - http://www.scopus.com/inward/record.url?scp=67449135811&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdp281

DO - 10.1093/annonc/mdp281

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 19497945

AN - SCOPUS:67449135811

SN - 0923-7534

VL - 20

SP - 1

EP - 6

JO - Annals of Oncology

JF - Annals of Oncology

IS - SUPPL.7

ER -

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this